Category: Drug Side Effects
Invokana Heart Attack Class Action Lawsuit
Recent studies have linked the type 2 diabetes medication Invokana to cardiovascular side effects including blood clots that could lead to a heart attack. Free Invokana Class Action Lawsuit Evaluation: If you or a loved one was injured by Invokana,...
Farxiga Class Action Lawsuit
Update: Farxiga Litigation Centralized in New York April 13, 2017 – The U.S. Judicial Panel on Multidistrict Litigation (JPML) has ordered that all federal lawsuits involving Farxiga and Xigduo XR be centralized for pretrial handling in the Southern District of...
Jardiance Class Action Lawsuit
Update: FDA Panel Recommends Approval of Jardiance for Cardiovascular Indication June 29, 2016 – An FDA advisory committee voted yesterday 12-11 that substantial evidence exists to establish that Jardiance reduces cardiovascular or CV death in adults with type 2 diabetes...
Xigduo XR Class Action Lawsuit
Update: Xigduo XR Litigation Centralized in New York April 13, 2017 – The U.S. Judicial Panel on Multidistrict Litigation (JPML) has ordered that all federal lawsuits involving Farxiga and Xigduo XR be centralized for pretrial handling in the Southern District...
Glyxambi Class Action Lawsuit
Glyxambi may be Linked to Rhabdomyolysis, FDA Warns December 1, 2017 – The U.S. Food & Drug Administration (FDA) is investigating a potential link between Glyxambi and other type 2 diabetes medications in its class and a severe muscular condition...
Invokamet Class Action Lawsuit
Update: FDA Requires Boxed Warning on Amputation Risk with Invokamet May 16, 2017 – Based on the final results of 2 long-term clinical trials, FDA has concluded that type 2 diabetes patients who take Invokana or Invokamet are twice as...
Invokana Class Action Lawsuit
Update: FDA Requires Boxed Warning on Amputation Risk with Invokana May 16, 2017 – Based on the final results of 2 long-term clinical trials, FDA has concluded that type 2 diabetes patients who take Invokana or Invokamet are twice as...
Victoza Class Action Lawsuit
Update: LEADER Trial Finds Increased Pancreatic Cancer Risk with Victoza June 17, 2016 – A study published this month in the New England Journal of Medicine (NEJM) identified a potential increased risk of pancreatic cancer in type 2 diabetes patients treated...